Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Ski regulates YAP1 and cardiac myofibroblast function
FY 2014-15
Summary
Fibrosis is the result of abnormal wound-healing, whereby excess connective tissue is formed in an injured organ or tissue. Fibrosis can develop in nearly any tissue in the body; thus it is associated with a broad range of diseases. To date, there are no effective drugs or therapies to treat patients with fibrosis, despite the widespread occurrence of the condition. In heart disease patients, cardiac fibrosis is the main contributing factor to the progression into a state of heart failure as the heart muscle stiffens and is no longer able to function properly. The type of cell responsible for the initiation and spread of fibrosis is the myofibroblast; this cell type secretes large amounts of collagen, the main protein found in scar tissue. Our lab previously found that a small protein, Ski, is able to hinder a myofibroblast's ability to proliferate and produce collagen after a heart attack (myocardial infarction), suggesting that it may stop or reverse acute cardiac fibrosis. Our more recent studies in cardiac myofibroblasts have shown that Ski specifically modulates the levels of another protein called YAP1, which is normally associated with cell survival in injured tissue. My goal is to determine precisely how Ski regulates the function and expression of YAP1 and if a dysfunction in this relationship contributes to cardiac fibrosis. By characterizing this relationship at the level of the cell, we can better understand fibrosis at the level of the tissue and organ. Using the data from this research, we can propose and test possible interventions to better treat patients suffering from not only cardiac fibrosis and heart failure, but also fibrotic diseases in other tissues.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331547
Name
Landry Natalie M
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Ski regulates YAP1 and cardiac myofibroblast function
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiac Fibrosis; Extracelullar Matrix; Heart Failure; Hippo Pathway; Myocardial Infarction; Ski; Tgf-Beta; Yap1
Abstract
Fibrosis is the result of abnormal wound-healing, whereby excess connective tissue is formed in an injured organ or tissue. Fibrosis can develop in nearly any tissue in the body; thus it is associated with a broad range of diseases. To date, there are no effective drugs or therapies to treat patients with fibrosis, despite the widespread occurrence of the condition. In heart disease patients, cardiac fibrosis is the main contributing factor to the progression into a state of heart failure as the heart muscle stiffens and is no longer able to function properly. The type of cell responsible for the initiation and spread of fibrosis is the myofibroblast; this cell type secretes large amounts of collagen, the main protein found in scar tissue. Our lab previously found that a small protein, Ski, is able to hinder a myofibroblast's ability to proliferate and produce collagen after a heart attack (myocardial infarction), suggesting that it may stop or reverse acute cardiac fibrosis. Our more recent studies in cardiac myofibroblasts have shown that Ski specifically modulates the levels of another protein called YAP1, which is normally associated with cell survival in injured tissue. My goal is to determine precisely how Ski regulates the function and expression of YAP1 and if a dysfunction in this relationship contributes to cardiac fibrosis. By characterizing this relationship at the level of the cell, we can better understand fibrosis at the level of the tissue and organ. Using the data from this research, we can propose and test possible interventions to better treat patients suffering from not only cardiac fibrosis and heart failure, but also fibrotic diseases in other tissues.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Landry, Natalie M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~